Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Marks

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|November 5, 1997
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanomaE T Creagan, K M Rowland, V J Suman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patientsZ Sun, J Chen, J Aakre, et al.
The Pharmacogenomics Journal|July 2, 2014
Wnt signaling pathway pharmacogenetics in non-small cell lung cancerD J Stewart, D W Chang, Y Ye, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase II trial of topotecan for the treatment of mesotheliomaA W Maksymiuk, R F Marschke, H D Tazelaar, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2004
Environmental tobacco smoke exposure in women with lung cancerM de Andrade, J O Ebbert, J A Wampfler, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
American Journal of Clinical Oncology|October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment GroupR J Kirschling, J P Grill, R S Marks, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|November 5, 1997
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanomaE T Creagan, K M Rowland, V J Suman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patientsZ Sun, J Chen, J Aakre, et al.
The Pharmacogenomics Journal|July 2, 2014
Wnt signaling pathway pharmacogenetics in non-small cell lung cancerD J Stewart, D W Chang, Y Ye, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase II trial of topotecan for the treatment of mesotheliomaA W Maksymiuk, R F Marschke, H D Tazelaar, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2004
Environmental tobacco smoke exposure in women with lung cancerM de Andrade, J O Ebbert, J A Wampfler, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
American Journal of Clinical Oncology|October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment GroupR J Kirschling, J P Grill, R S Marks, et al.
Pageof 4